Search Results 581-590 of 16617 for alopecia

1. A Study to Evaluate Patient Experience and Satisfaction with Predictive Genomic Testing Ordered Through SL3 - Mayo Clinic

   The purpose of this study is to better understand the impact of predictive genomic testing in the healthy adult population by assessing decisional satisfaction/ ...

2. Erectile dysfunction - Doctors and departments - Mayo Clinic

   Understand what can cause the inability to get and keep an erection firm enough for sex and the possible treatment options.

3. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

   Recovery to Grade 1 or baseline of any non-hematologic toxicities due to prior treatments, excluding alopecia and Grade 2 peripheral neuropathy. Adequate ...

4. A Study to Evaluate Abemaciclib to Treat Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration - Mayo Clinic

   0] Grade ≤1) from the acute effects of chemotherapy (except for residual alopecia or Grade 2 peripheral neuropathy) prior to enrollment, or other toxicity ...

5. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

   ... alopecia and Grade 2, prior platinum-therapy related neuropathy. As judged by the investigator, active gastrointestinal disease or other condition that will ...

6. Movement disorders - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

7. Movement disorders - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

8. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

   alopecia) before trial treatment in Second Course Phase is started. If participant received major surgery or radiation therapy of >30 Gray (Gy), they must ...

9. Electrophysiological Biomarkers for Parkinson's Disease - Mayo Clinic

   This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

10. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    ... alopecia) and/or in whom ≥ 25 percent (%) of the bone marrow was irradiated. Patients who have a previous or concurrent cancer that is distinct in primary ...